Advertisement

Topics

Week in Review: Biosense Exercises $75 Million Option for China Rights to Neovacs' Lupus Immunotherapy

00:54 EDT 14 Oct 2018 | ChinaBio Today

Deals and Financings 

  • Biosense Global, a New Jersey-Suzhou company, exercised a $75 million option for China rights to a lupus immunotherapy developed by Neovacs of France;
  • Daiichi Sankyo acquired China rights to Penthrox, a fast-acting non-opioid analgesic, from Medical Developments of Australia in a $32.5 million agreement;
  • Lepu Medical Technology of Beijing invested $22 million in New York-based Rgenix and will have China rights to Rgenix' cancer drug candidates;
  • Deep Intelligent Pharma, a Beijing healthcare AI startup, raised $15 million in a Series B round from Sequoia Capital for AI-assisted drug R&D;
  • BeiGene will collaborate with San Diego's MEI Pharma to test MEI's PI3K delta inhibitor together with BeiGene's BTK inhibitor in patients with B-cell malignancies;
  • Amor Medical Sci-Tech, a Suzhou-Germany JV, formed a collaboration with IME of Holland to develop novel resorbable wound treatment devices;
  • Jinxin Fertility received a strategic investment led by Warburg Pincus and CNCB Investment to expand its reproductive services footprint;

Trials and Approvals

  • I-Mab Biopharma of Shanghai dosed the first patient in a China Phase II trial of its selective IL-6 blocker in patients with ulcerative colitis;
  • Alphamab Oncology of Suzhou started a Phase I trial of its humanized PD-L1/CTLA-4 bispecific antibody in Australia; a China trial was also approved;
  • Yisheng Biopharma, a Beijing immunomodulatory company, reported the CFDA will allow a Phase III trial of its PIKA® rabies vaccine.

Stock Symbols: (Paris: ALNEV) (TO: 4568) (ASX: MVP) (NSDQ: BGNE; HK: 06160) (NSDQ: MEIP)

Share this with colleagues:

Original Article: Week in Review: Biosense Exercises $75 Million Option for China Rights to Neovacs' Lupus Immunotherapy

NEXT ARTICLE

More From BioPortfolio on "Week in Review: Biosense Exercises $75 Million Option for China Rights to Neovacs' Lupus Immunotherapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lupus
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...